Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. - Wikidata - awgldk - TriplyDB

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.

http://www.wikidata.org/entity/Q35195815

about

The associations between Parkinson's disease and cancer: the plot thickens The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1 Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation.Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression LRRK2 and ubiquitination: implications for kinase inhibitor therapy The association between Parkinson's disease and melanoma: a systematic review and meta-analysis.Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson's disease and beyond Cellular processes associated with LRRK2 function and dysfunction Cutaneous malignant melanoma and Parkinson disease: Common pathways?Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-2016).The relevance of gender in Parkinson's disease: a review.The LRRK2-macroautophagy axis and its relevance to Parkinson's disease Clinical Features of LRRK2 Carriers with Parkinson's Disease.Is PARKIN parkinsonism a cancer predisposition syndrome?Parkinson disease (PARK) genes are somatically mutated in cutaneous melanoma.Increased risk of brain tumor in patients with Parkinson's disease: a nationwide cohort study in Taiwan.Biological and Clinical Implications of Comorbidities in Parkinson's Disease.The LRRK2 signalling system.Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stress.Parkinson's disease and colorectal cancer risk-A nested case control study.Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease.

P2860

Q26778641-0FCCA1D4-DD45-4728-9E2D-B08432EE0EA8 Q28118941-2E4E2E11-F893-47DE-9583-C715CFCF1156 Q28822211-038CD0AC-462E-4E2F-A63C-A0735EA4815B Q30239964-68FA1E36-EFBC-419B-B11E-A62A4CFD5120 Q36073860-233EB31F-DD93-4E40-9D25-5FD750BB3DC5 Q36185165-C3694866-5441-40DD-8F70-832EBA67A913 Q36243422-02445DCE-7041-411B-AB8F-039A226C1987 Q38363786-F1B929EE-162F-4ACA-AA74-E35A8C52BAC2 Q38433725-B3A1E1E7-4023-4CEC-9DA1-C9C48DFFEFFE Q38985873-1143EA43-8E11-44F1-9B7A-2109DBB8C5E5 Q39002226-3EF65204-E0A7-46C9-ADE1-B6E8D2FBB44A Q39039214-D05A69D1-0036-4651-80B0-175500D9BAF5 Q39137355-989DDB1E-3B36-47F1-8C48-27F36E80D85E Q39206423-C56021A0-8EBE-4920-B3F9-3D0E9D898FCD Q39624136-12ADF36A-79EF-4EFC-86E4-0AF12EBB883B Q40200165-192C32EA-5D91-482C-91C7-0635C2084114 Q40385346-15AEBB69-03D3-4B97-B50C-9A17C8F9EA31 Q47137783-0C120988-1645-4FCB-8EEA-1096845DDF84 Q47225650-6DBDE5CF-CDB0-4A43-8659-4BD0D3BB2CAB Q48192270-E9D818D5-60DD-4DD5-AFF6-DD7E46962957 Q49651549-2492787F-1334-4AB5-8075-42049B364FD1 Q54334574-B01AFDA8-EFC0-4518-96D8-22BB928C30B4 Q55014055-F484CA79-BBF7-4245-88A4-FF862E749B05

P2860

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.

http://www.wikidata.org/entity/Q35195815

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Higher frequency of certain ca ...... on disease: a pooled analysis.

@ast

Higher frequency of certain ca ...... on disease: a pooled analysis.

@en

type

label

Higher frequency of certain ca ...... on disease: a pooled analysis.

@ast

Higher frequency of certain ca ...... on disease: a pooled analysis.

@en

altLabel

Higher Frequency of Certain Ca ...... arriers With Parkinson Disease

@en

prefLabel

Higher frequency of certain ca ...... on disease: a pooled analysis.

@ast

Higher frequency of certain ca ...... on disease: a pooled analysis.

@en

P1433

Q35195815-FFD133AE-5BAA-4947-B455-F4CFB6BE25AE

P1476

Q35195815-DCE9952A-72E2-4F01-950B-05907482C15C

P2093

Q35195815-11F1DA7E-1641-4100-AF5C-8657F1D1A136

Q35195815-21FF5613-EC0E-4911-BEFB-952D251E7CDA

Q35195815-3B559905-B1E0-49DB-8D70-8343D63CF060

Q35195815-3CA9C939-8A63-4B8E-9F30-4E789B2E396A

Q35195815-4BC8F53E-C6E3-40B8-B903-03328AE9191D

Q35195815-59586E1E-E4A6-4FE0-80CF-0AE6115C0C6B

Q35195815-5D8E301F-70D6-4F97-A010-19B4839B5FAA

Q35195815-91434678-4223-4792-933C-2CC2AE77058B

Q35195815-AF623658-F325-4FED-9C75-C3794522555C

Q35195815-B9A06379-E469-4293-B37F-44630D4D2710

P2860

Q35195815-167D66E7-5832-4FD5-ABC7-87927417AD25

Q35195815-368FE39D-F1CA-4070-9FB0-4E0909A0D795

Q35195815-385449E0-91F5-4AAE-85C3-B0318EC2E7B9

Q35195815-41FF54ED-CBFA-4E78-9D92-4489876BE7F2

Q35195815-4EAEDCAE-C3E3-4F43-8129-C42CB7B41D3D

Q35195815-6073E3E6-97FF-4575-A9E3-DEEF0CBC8BA4

Q35195815-651F557B-291D-499C-AB60-2CCE9639CEDE

Q35195815-6F80DC38-BD2E-43F9-9493-335AB614BECA

Q35195815-7B4A2285-F23D-4FCD-9C51-AF8F37912D15

Q35195815-8B179A32-6278-4AAE-97AC-B562DC800538

P304

Q35195815-C7E8CEDF-8E2E-4A11-AC5F-ACC9071CA774

P31

Q35195815-82A7570B-5AF9-4924-B4E6-A872733860F7

P356

Q35195815-D5C8A388-D9C8-4E35-8F01-01AC6B58A3C3

P407

Q35195815-E668A2C6-C855-41E5-9BA2-C0888D932889

P433

Q35195815-AD2B2663-BF01-459F-BDA0-5C79147E1DED

P478

Q35195815-4233040F-51E1-4A87-99E1-6C6B15969017

P50

Q35195815-214BF7E5-4138-4215-B428-86F99F4F432B

Q35195815-30793F0A-A4C3-4C54-9013-75F1EB7DF56B

Q35195815-5078A6BC-F282-412D-A18B-06B3A5048F62

Q35195815-7471EC13-AA29-4450-8DD7-14D9A7AB53DE

P577

Q35195815-EAED4409-26F8-4E46-9F5B-70EB090EAF58

P5875

Q35195815-0C2D9DC6-5FF4-4544-B0C6-C2BF8132AB25

P698

Q35195815-869A4D6D-EC8B-4C4A-8432-C37FBBD5137A

P921

Q35195815-C7B30B9D-87CB-43EF-9711-AB19E6C7DC56

P932

Q35195815-797B28A4-6708-4670-BCBC-F0AFB142D264

P356

JAMANEUROL.2014.1973

P1433

P1476

Higher frequency of certain ca ...... on disease: a pooled analysis.

@en

P2093

Anat Mirelman

http://www.w3.org/2001/XMLSchema#string

Bjorg Waro

http://www.w3.org/2001/XMLSchema#string

Eitan Friedman

http://www.w3.org/2001/XMLSchema#string

Ilir Agalliu

http://www.w3.org/2001/XMLSchema#string

Jan Aasly

http://www.w3.org/2001/XMLSchema#string

Javier Ruiz-Martinez

http://www.w3.org/2001/XMLSchema#string

Jose Felix Marti-Masso

http://www.w3.org/2001/XMLSchema#string

Marta San Luciano

http://www.w3.org/2001/XMLSchema#string

Rivka Inzelberg

http://www.w3.org/2001/XMLSchema#string

Sharon Hassin-Baer

http://www.w3.org/2001/XMLSchema#string

P2860

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

Kinase activity of mutant LRRK2 mediates neuronal toxicity

Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism

LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease

The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells.

A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease.

Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

Meta-analysis of the relationship between Parkinson disease and melanoma.

Atypical cancer pattern in patients with Parkinson's disease.

P304

58-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMANEUROL.2014.1973

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

Rachel Saunders-Pullman

Avi Orr-Urtreger

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268449746

http://www.w3.org/2001/XMLSchema#string

P698

25401981

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4366130

http://www.w3.org/2001/XMLSchema#string